(FRCJ) UBS MSCI Japan Socially - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1230561679
FRCJ: ESG, Stocks, Equities, Japan, Large-Cap
The UBS MSCI Japan Socially Responsible UCITS JPY A-dis ETF (XETRA:FRCJ) is an investment vehicle that tracks the Morningstar Japan TME NR JPY index, providing exposure to Japanese large-cap equities with a focus on socially responsible investing.
This German-originated ETF is designed for investors seeking to align their investments with their values while gaining access to Japans significant market. The funds underlying index is constructed to represent the Japanese equity markets performance, with a tilt towards companies that demonstrate strong environmental, social, and governance (ESG) practices.
Analyzing the ETFs recent price action, we observe a stable trend, with the last price recorded at 23.45. The short-term moving averages (SMA20 at 23.44 and SMA50 at 22.86) indicate a potential bullish crossover, suggesting a positive outlook in the near term. The longer-term SMA200 at 23.00 provides a level of support, indicating that the ETF has been consolidating around this critical level.
With an Assets Under Management (AUM) of approximately 79.793 billion EUR, the fund demonstrates significant investor confidence and liquidity. This substantial AUM also implies that the ETF is well-established and capable of absorbing large trades without significantly impacting the market price.
Forecasting the ETFs future performance based on the provided technical and fundamental data, we anticipate a potential upward trajectory. The proximity of the current price to the SMA20 and the bullish crossover indicated by the SMA20 and SMA50 suggest a near-term uptrend. Additionally, the substantial AUM and the ETFs tracking of a well-established index like the Morningstar Japan TME NR JPY provide a foundation for stable long-term growth. However, investors should monitor the ATR (0.29 or 1.25%) for potential volatility and adjust their strategies accordingly. A break above the 52-week high of 24.50 could signal further upside potential, while a drop below the SMA200 at 23.00 might indicate a need to reassess the investment.
Additional Sources for FRCJ ETF
FRCJ ETF Overview
Market Cap in USD | 91,842m |
Category | Japan Large-Cap Blend Equity |
TER | 0.20% |
IPO / Inception | 2015-07-22 |
FRCJ ETF Ratings
Growth Rating | 39.5 |
Fundamental | - |
Dividend Rating | 53.2 |
Rel. Strength | -14.4 |
Analysts | - |
Fair Price Momentum | 21.56 EUR |
Fair Price DCF | - |
FRCJ Dividends
Dividend Yield 12m | 2.07% |
Yield on Cost 5y | 2.70% |
Annual Growth 5y | 3.65% |
Payout Consistency | 97.3% |
Payout Ratio | % |
FRCJ Growth Ratios
Growth Correlation 3m | 3.5% |
Growth Correlation 12m | 63.3% |
Growth Correlation 5y | 46.9% |
CAGR 5y | 5.41% |
CAGR/Max DD 5y | 0.25 |
Sharpe Ratio 12m | -0.08 |
Alpha | 0.31 |
Beta | 0.804 |
Volatility | 13.24% |
Current Volume | 5.4k |
Average Volume 20d | 5k |
As of June 15, 2025, the stock is trading at EUR 23.10 with a total of 5,401 shares traded.
Over the past week, the price has changed by -1.09%, over one month by -1.66%, over three months by -0.82% and over the past year by +9.70%.
Partly, yes. Based on ValueRay´s Analyses, UBS MSCI Japan Socially (XETRA:FRCJ) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.47 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FRCJ is around 21.56 EUR . This means that FRCJ is currently overvalued and has a potential downside of -6.67%.
UBS MSCI Japan Socially has no consensus analysts rating.
According to our own proprietary Forecast Model, FRCJ UBS MSCI Japan Socially will be worth about 24.4 in June 2026. The stock is currently trading at 23.10. This means that the stock has a potential upside of +5.41%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.4 | 5.4% |